Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment

NANot yet recruitingINTERVENTIONAL
Enrollment

3,492

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

May 1, 2029

Study Completion Date

July 31, 2029

Conditions
Opioid Use Disorder
Interventions
OTHER

care coordination implementation strategies

The intervention will be a bundle of implementation strategies developed during a prior study and informed by the multi-team systems framework. Core implementation strategies are expected to include a standardized ED substance use navigator note (with education and billing support), a mechanism for sharing PHI information across ED-clinic pairs that use different electronic health record systems, an improved ability for patients to directly contact EDs and clinics, ensuring ED and outpatient teams mutually understand each other roles, implementing procedures to increase capacity for same-day outpatient buprenorphine refills, and interactive problem solving with an external facilitation team. Strategies will be adapted to local contexts at each site.

Trial Locations (4)

92243

El Centro Regional Medical Center Emergency Department, El Centro

92868

University of California Irvine Emergency Department, Irvine

95667

Marshall Medical Center Emergency Department, Placerville

95817

University of California Davis Emergency Department, Sacramento

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of California, Davis

OTHER

NCT07024498 - Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment | Biotech Hunter | Biotech Hunter